Cornea/External Disease News

One of the many significant benefits of my membership in the CEDARS/ASPENS society is our ability to reach out for “curbside consults.”

The Systane iLux2 meibomian gland dysfunction thermal pulsation system delivers heat and pressure therapy while allowing patients to visualize their treatment, according to an Alcon press release.

Axim Biotechnologies has developed a rapid quantitative tear test to detect an inflammatory biomarker for dry eye disease, according to a press release.

Real-world outcomes from the PERSPECTIVE study showed long-term efficacy of cyclosporine A 0.1% cationic emulsion in controlling severe keratitis in patients with dry eye disease.

Severe dry eye disease symptoms and signs were found to be associated with depression in a study, suggesting consideration of depression as a possible comorbidity when managing patients with dry eye.

Herpes simplex keratitis is a challenge to diagnose and treat. My guest columnist this month is Sonal S. Tuli, MD, MEd, professor and chair of the department of ophthalmology at the University of Florida.

Adults with thyroid eye disease and diabetes have a higher prevalence of diplopia, strabismus and sight-threatening disease compared with those without diabetes, according to study findings published in Endocrine Practice.

The first of two pivotal phase 3 trials that will assess the safety and efficacy of Brimochol PF for the treatment of presbyopia is underway, according to a press release from Visus Therapeutics.

Many ophthalmologists depend on optometrists in their referral network as a source of surgical patients and for postoperative care.

To celebrate the 40th anniversary of Healio/Ocular Surgery News, the Associate Medical Editors are sharing what they think are the most important ophthalmic innovations of the 2010s.